« Previous
Next »
Journal of the American College of Cardiology
Volume 52, Issue 8
, Pages 644-651
, 19 August 2008
Lack of Association Between Adrenergic Receptor Genotypes and Survival in Heart Failure Patients Treated With Carvedilol or Metoprolol
References
- Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146
- . Heart failure. Lancet. 2005;365:1877–1889
- . Genetic causes of human heart failure. J Clin Invest. 2005;115:518–526
- . Redefining heart failure: the utility of genomics. J Am Coll Cardiol. 2006;48:1289–1298
- . The year in heart failure. J Am Coll Cardiol. 2007;50:2344–2351
- . Pharmacogenetics of beta-1- and beta-2-adrenergic receptors. Pharmacology. 2000;61:167–173
- . Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol. 2003;43:381–411
- . Mechanisms of disease: beta-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failure. Nat Clin Pract Cardiovasc Med. 2005;2:475–483
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–2007
- Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106:2194–2199
- . Role of beta adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis. Eur J Heart Fail. 2008;10:3–13
- . Pharmacogenetics of β-blockers. Pharmacotherapy. 2007;27:874–887
- . A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem. 1999;274:12670–12674
- Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure. Pharmacogenet Genomics. 2005;15:137–142
- . Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics. 2003;13:379–382
- A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure. Proc Natl Acad Sci U S A. 2006;103:11288–11293
- Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med. 2003;9:1300–1305
- Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to β-blocker therapy. Pharmacogenet Genomics. 2005;15:227–234
- beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure. Clin Pharmacol Ther. 2005;77:127–137
- . Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA. 2007;297:1551–1561
- Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure. Am J Cardiol. 2007;99:250–255
- . Cardiovascular Genetic and Genomic Sciences. http://cardiology.duke.edu/modules/div_cv_rsch_cggs/Accessed December 2005 to July 2006
- . Database Registry of the Intermountain Heart Collaborative Study. http://www.clinicaltrials.gov/ct2/show/NCT00406185?term=NCT00406185&rank=1Accessed April 2006 to July 2006
- The Social Security Death Master File. http://www.ssdmf.comAccessed March 2007
- . Polymorphisms of cardiac presynaptic alpha2C adrenergic receptors: diverse intragenic variability with haplotype-specific functional effects. Proc Natl Acad Sci U S A. 2004;101:13020–13025
- . Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc B. 1977;39:1–38
- . R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2007;
- The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424–1433
- The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure. Eur J Heart Fail. 2005;7:966–973
- An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study. Eur J Heart Fail. 2003;5:463–468
- . Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol. 2008;51:569–576
- Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study. Am J Respir Crit Care Med. 2006;174:1101–1109
- . Genetic variation within the beta1-adrenergic receptor gene results in haplotype-specific expression phenotypes. J Cardiovasc Pharmacol. 2008;51:106–110
Drs. Sehnert, Daniels, Elashoff, and Wingrove are paid employees of CardioDx, Inc. This work was funded by CardioDx, Inc.
PII: S0735-1097(08)01936-0
doi: 10.1016/j.jacc.2008.05.022
© 2008 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of the American College of Cardiology
Volume 52, Issue 8
, Pages 644-651
, 19 August 2008
